Aomori Prefectural Central Hospital

Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer

Toshiaki Watanabe, Michio Itabashi, Yasuhiro Shimada et al. · International Journal of Clinical Oncology · 2015 · 599 citations · Full text

Japanese Society, Surgical Oncology, Jsccr Guideline Committee +14

Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegafur–0.4M gimestat–1M otastat potassium) in advanced gastric cancer patients

Yuh Sakata, Atsushi Ohtsu, N Horikoshi et al. · European Journal of Cancer · 1998 · 564 citations

Medicinal Chemistry, Oncology, Gastrointestinal Oncology +9

Transforming growth factor-?1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma

Yukihiro Hasegawa, Shingo Takanashi, Yutaka Kanehira et al. · Cancer · 2001 · 242 citations

Phase II study of S-1, a novel oral fluoropyrimidine derivative, in patients with metastatic colorectal carcinoma

Atsushi Ohtsu, Hideo Baba, Yuh Sakata et al. · British Journal of Cancer · 2000 · 205 citations · Full text

Axial Symptoms After Cervical Laminoplasty With C3 Laminectomy Compared With Conventional C3–C7 Laminoplasty

Kazunari Takeuchi, Tōru Yokoyama, Shuichi Aburakawa et al. · Spine · 2005 · 184 citations